Automated interpretations of single-lead electrocardiograms predict incident atrial fibrillation: The VITAL-AF trial

Heart Rhythm. 2024 Sep;21(9):1640-1646. doi: 10.1016/j.hrthm.2024.04.085. Epub 2024 Apr 29.

Abstract

Background: Single-lead electrocardiograms (1L ECGs) are increasingly used for atrial fibrillation (AF) detection. Automated 1L ECG interpretation may have prognostic value for future AF in cases in which screening does not result in a short-term AF diagnosis.

Objective: We sought to investigate the association between automated 1L ECG interpretation and incident AF.

Methods: VITAL-AF was a randomized controlled trial investigating the effectiveness of screening for AF by 1L ECGs. For this study, participants were divided into 4 groups based on automated classification of 1L ECGs. Patients with prevalent AF were excluded. Associations between groups and incident AF were assessed by Cox proportional hazards models adjusted for risk factors. The start of follow-up was defined as 60 days after the latest 1L ECG (as some individuals had numerous screening 1L ECGs).

Results: The study sample included never screened (n = 16,306), normal (n = 10,914), other (n = 2675), and possible AF (n = 561). Possible AF had the highest AF incidence (5.91 per 100 person-years; 95% confidence interval [CI], 4.24-8.23). Possible AF was associated with greater hazard of incident AF compared with normal (adjusted hazard ratio, 2.48; 95% CI, 1.66-3.71). Other was associated with greater hazard of incident AF compared with normal (1.41; 95% CI, 1.04-1.90).

Conclusion: In patients undergoing AF screening with 1L ECGs without prevalent AF or AF within 60 days of screening, presumptive positive and indeterminate 1L ECG interpretations were associated with future AF. Abnormal 1L ECG recordings may identify individuals at higher risk for future AF.

Keywords: Atrial fibrillation; Atrial fibrillation risk stratification; Atrial fibrillation screening; Consumer devices; Single-lead electrocardiograms.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / physiopathology
  • Electrocardiography* / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment / methods
  • Risk Factors